Details for 2013811327
Up to date per 26.04.2026
Actions
Details for 2013811327
Granted/Registered
European Patent
14.10.2015 A
25.10.2017 B1
05.12.2012
US
201261733518 P
15.03.2013
US
201361793530 P
04.10.2013
US
201361886916 P
17.10.2013
US
201361892188 P
C12N 15/113 20100101AFI20170308BHEP
Owner
Alnylam Pharmaceuticals, Inc.675 West Kendall Street, Henri A. Termeer Square Cambridge, MA 02142US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
BORODOVSKY, Anna300 Third Street 3rd Floor Cambridge, MA 02142US
KALLANTHOTTATHIL, Rajeev G.300 Third Street 3rd Floor Cambridge, MA 02142US
FITZGERALD, Kevin300 Third Street 3rd Floor Cambridge, MA 02142US
FRANK-KAMENETSKY, Maria300 Third Street 3rd Floor Cambridge, MA 02142US
QUERBES, William300 Third Street 3rd Floor Cambridge, MA 02142US
MAIER, Martin300 Third Street 3rd Floor Cambridge, MA 02142US
CHARISSE, Klaus300 Third Street 3rd Floor Cambridge, MA 02142US
KUCHIMANCHI, Satyanarayana300 Third Street 3rd Floor Cambridge, MA 02142US
MANOHARAN, Muthiah300 Third Street 3rd Floor Cambridge, MA 02142US
MILSTEIN, Stuart300 Third Street 3rd Floor Cambridge, MA 02142US
Information about Fees